Replies to post #1191 on Revive Therapeutics Ltd (RVVTF)

[MrNormall]

In my mind timed perfectly. If we get news before the next one it won't matter. Should be in low orbit by then.

[Fress]

Thats why this will continue to fall no financing share count increased tremendously. 200k on the books to keep the lights on or less from last 10q. Also director have given themselves tens of millions of shares as bonuses.

$RVVTF

[Fress]

Another in a week or so exactly tens of millions of shares hitting the market. Thats why goof financing is key to biotechs. I hate to say it But I think .06 .07 Cents is where is this is going over the next month. Not dosing first patient till FALL thats what the CEO said a week or so ago. If the IND is delayed this stock is really going to plummet back to its 52 week lows.

Are you guys going to wait till Fall while they dump tens of millions of shares during that time. You won't be able to stomach it.

Revive Therapeutics preparing to submit paperwork for a Phase 3 FDA study of Bucillamine (3 minutes 20 seconds CEO confirms no first dosing till Fall)

$RVVTF